Skip to content
Anuncia Medical Inc. logo — Empowering patients with innovative, noninvasive solutions f...

Anuncia Medical Inc.

Empowering patients with innovative, noninvasive solutions for long-term cerebral health and reduced medical intervention.

Founded 2018 11-50 employees Seed Total: $19.00K Biotechnology, Health Care

General Information

Company Name Anuncia Medical Inc.
Founded Year 2018
Founders / Decision Makers
Team member Team member
Employees 11-50
Industries Biotechnology, Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Anuncia Medical Inc.. To contact Anuncia Medical Inc., visit anunciainc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Anuncia Medical Inc. compare?

A PDF of Anuncia Medical Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Anuncia Medical Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Anuncia Medical Inc.

Anuncia Medical Inc. is a revolutionary MedTech startup dedicated to providing innovative, noninvasive therapeutic solutions in the Cerebrospinal Fluid (CSF) Management sector. With approvals in both the US and EU, their clinically validated devices target the high rate of ventriculoperitoneal (VP) shunt occlusion, which currently has alarming failure rates, leading to costly repeat brain surgeries. Established in collaboration with Boston Children’s Hospital and stemming from Alcyone Therapeutics in 2018, Anuncia's advanced technologies bring relief to patients with hydrocephalus and other CSF disorders by reducing the need for frequent surgical interventions. The core technology features a unique mechanism involving a soft silicone dome, facilitating noninvasive, retrograde flushing of CSF to clear occluded catheters. Initial clinical evidence demonstrates that the ReFlow system effectively restores flow and alleviates symptoms through acute intervention, with successful follow-ups extending up to 3 years. Encouraged by this data, neurosurgeons are recommending ReFlow for preventive use in high-risk patients. Furthermore, the FDA has recognized the benefits of ReFlow, granting it Breakthrough Device status in 2021, which provides regulatory and reimbursement advantages. With profitable reimbursement in place, Anuncia plans to launch its next-generation ReFlow Mini product line and continue clinical studies to support adoption and premium reimbursement. Positioned to lead in CSF management, Anuncia aims to improve clinical outcomes and quality of life while reducing healthcare costs. Their recognition includes an Honorable Mention in the Fast Company 2021 World-Changing Ideas Awards and being included in MDDI’s The Ultimate List of Private Companies to Watch. The latest investment comes in the form of a $1.00K Seed Round investment received on 20 October 2023. While the specific investors are not listed, this injection of funds is poised to further propel Anuncia Medical Inc.'s innovative and impactful mission in revolutionizing CSF management.

Business keywords: MedTech, Cerebrospinal Fluid Management, Hydrocephalus, Noninvasive Solutions, Clinical Validation, Healthcare Costs, FDA Breakthrough Device, Ventriculoperitoneal Shunt, Patient-Centric, Innovation, Clinical Studies, Reimbursement Strategies, Regulatory Advantages

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $1.00K -
20 Oct 2023
Angel Round $18.00K 1
Arizona Technology Investors
09 Jun 2023
Angel Round Undisclosed 1
Arizona Technology Investors
02 Dec 2021

Anuncia Medical Inc. Alternatives & Competitors

View All Alternatives
Anuncia Medical Inc. vs
Rhaeos
Rhaeos United States

🩹wearable sensors // FDA breakthrough devices //MedTech Innovator Winner (#1 out of >1000) // NSF &...

Grant
25 employees
Biotechnology, Hardware
Anuncia Medical Inc. vs
Autem Therapeutics
Autem Therapeutics United States

EM-Powering Cancer Care

Series A
16 employees
Biotechnology, Health Care
Anuncia Medical Inc. vs
Impulse Dynamics
Impulse Dynamics United States

A cardiac medical device company determined to improve the lives of heart failure patients through C...

Venture round
239 employees
Biotechnology, Health Care

FAQ About Anuncia Medical Inc.

Empowering patients with innovative, noninvasive solutions for long-term cerebral health and reduced medical intervention.
Anuncia Medical Inc. was founded in 2018.
Anuncia Medical Inc. operates in Biotechnology and Health Care. Its work centres on MedTech, Cerebrospinal Fluid Management, Hydrocephalus and Noninvasive Solutions.
Anuncia Medical Inc. has approximately 11-50 employees.
Anuncia Medical Inc. has completed 3 funding rounds, raising a total of $19.00K. The latest funding stage is Seed.
Top alternatives and competitors to Anuncia Medical Inc. include Rhaeos, Autem Therapeutics, Impulse Dynamics, Databean, Inc., Masimo. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Anuncia Medical Inc. and Rhaeos are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Anuncia Medical Inc., https://bouncewatch.com/company/anuncia-medical-inc, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout